MKI67 and hepatocellular carcinoma: The decrease of the proliferative marker Ki67 in miR-4510 transfected-tumors was obvious both at day 3 and day 6 of tumor growth (Figure 8C, middle panels), indicating that miR-4510 was capable of inhibiting the proliferation of HCC.